| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |